You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Persistent hematologic malignancy

Showing 1 - 25 of 7,272
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)

Not yet recruiting
  • Hematologic Cancer
  • Hematologic Malignancy
  • CBT for Fatigue
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2023

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Hematologic Malignancy Trial (Cold-stored platelet concentrate)

Not yet recruiting
  • Hematologic Malignancy
  • Cold-stored platelet concentrate
  • (no location specified)
Apr 14, 2023

Thoracic Scanographic Characteristics of Hematologic Malignancy

Recruiting
  • Mediastinal Diseases
  • analysis of thoracic scans
  • Toulouse, France
    Muriel Picard
Jan 12, 2023

Hematologic Malignancy Trial in Zhejiang (IBI322)

Recruiting
  • Hematologic Malignancy
  • IBI322
  • Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Sep 12, 2022

Venous Thromboembolism in Hematologic Malignancy and

Active, not recruiting
  • Thrombosis, Venous
  • +4 more
    • Toronto, Ontario, Canada
      Federico Carini
    Nov 21, 2022

    Oral Complications in Hematological Malignancies

    Not yet recruiting
    • Hematologic Malignancy
      • Assiut, Egypt
        Assiut university
      Mar 6, 2023

      Hematologic Malignancies Trial in Shanghai (GNC-035)

      Recruiting
      • Hematologic Malignancies
      • Guiyang, Guizhou, China
      • +3 more
      Jan 13, 2023

      Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

      Active, not recruiting
      • Hematologic Malignancy
      • Milwaukee, Wisconsin
        Froedtert Hospital
      Jan 31, 2023

      Participants Previously Treated With Century Therapeutics

      Not yet recruiting
      • Hematological Malignancy
      • Solid Tumor Malignancy
      • No Intervention
      • (no location specified)
      Mar 3, 2023

      Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

      Not yet recruiting
      • Hematopoietic Stem Cell Transplantation
      • Hematologic Malignancy
      • CliniMACS®
      • (no location specified)
      Oct 17, 2023

      SARS-CoV-2 Infection in Hematologic Tumors

      Active, not recruiting
      • SARS-CoV-2 Infection
      • Hematologic Malignancy
      • None intervention
      • Beijing, Beijing, China
        Peking University First Hospital
      Jan 13, 2023

      Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)

      Not yet recruiting
      • Hematological Malignancy
      • Neutropenia
      • Morgantown, West Virginia
        Aaron Cumpston
      Sep 12, 2022

      Hematologic Malignancy Trial in Boston (PATH-C)

      Not yet recruiting
      • Hematologic Malignancy
      • PATH-C
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Nov 23, 2023

      Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

      Not yet recruiting
      • Hematologic Malignancy
      • +2 more
      • Flow Cytometry
      • Nanjing, Jiangsu, China
      • +2 more
      Apr 17, 2023

      Cognitive Impairment, Hematologic Malignancy Trial in Birmingham (Modified ketogenic diet using an exogenous ketogenic formula,

      Recruiting
      • Cognitive Impairment
      • Hematologic Malignancy
      • Modified ketogenic diet using an exogenous ketogenic formula
      • Online cognitive training
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jan 31, 2023

      Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

      Recruiting
      • Neoplasm, Plasma Cell
      • Lymphoma
      • Comprehensive Geriatric Assessment
      • Toulouse, France
        University Hospital Toulouse
      Oct 12, 2022

      Prospective Validation of the OHI Index

      Recruiting
      • HLH
      • +4 more
        • Kfar Saba, Israel
        • +1 more
        May 21, 2023

        Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)

        Not yet recruiting
        • Hematologic Malignancy
        • Home Transfusion Program Components
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Aug 18, 2022

        After Adoptive Transfer of Genetically Modified Cell Products

        Recruiting
        • Relapsed Hematologic Malignancy
        • Refractory Hematologic Malignancy
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Feb 6, 2023

          Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

          Recruiting
          • Hematological Malignancy
          • Cancer-Related Anemia
          • Shengxuening Tablet
          • Ferrous succinate
          • Wuhan, Hubei, China
            Zhongnan Hospital of Wuhan University
          Mar 13, 2023

          Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

          Completed
          Has Results
          • Leukemia
          • Lymphoma
          • Total Lymphoid Irradiation
          • +10 more
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Oct 28, 2022

          Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

          Recruiting
          • Hematologic Malignancy
          • +4 more
          • Palliative Care
          • Usual Care
          • Boston, Massachusetts
            Massachusetts General Hospital Cancer Center
          Jan 24, 2023

          Hematologic Malignancy Trial (Cyclophosphamid, ATG)

          Not yet recruiting
          • Hematologic Malignancy
          • (no location specified)
          Oct 29, 2023

          Hematologic Malignancy Trial in Copenhagen (HM-PRO)

          Active, not recruiting
          • Hematologic Malignancy
          • HM-PRO
          • Copenhagen, Denmark
            Dept. of Hematology
          Jun 14, 2022